CARE Hospitals Logo
×

Dr. Sainath Bhethanabhotla

Consultant Medical Oncologist & Pediatric Hemato - Oncologist

Speciality

Medical Oncology, Haematology

Qualification

MD, DM (Medical Oncology)

Experience

7 Years

Location

CARE Hospitals, Banjara Hills, Hyderabad, CARE Hospitals Outpatient Centre, Banjara Hills, Hyderabad

Bio

Dr Sainath Bhethanabhotla is the best Medical Oncologists & Pediatric Hemato-Oncologist in Hyderabad working at the CARE Super Specialty Hospital & Transplant Centre – Banjara Hills, CARE Hospitals Outpatient Centre, Banjara Hills, and CARE Super Specialty Hospital – Musheerabad. With more than 7 years of expertise in the field of Oncology; Dr Sainath Bhethanabhotla has successfully operated on many patients around the world. Dr Sainath Bhetanabhotla completed MBBS from the Osmania Medical College; MD in the Pediatrics from All India Institute of Medical Sciences; and DM in the field of  Medical Oncology From All India Institute of Medical Sciences. 

Dr Sainath Bhethanabhotla Won Sorel Catherine Prize For Best Post Graduate in Pediatrics For The Year 2012. He also Stood 2nd in NNF Gold Medal Paper For The Year 2012 and Received Scholarship For Oral Presentation in SIOP-2015 in Cape Town, South Africa For The Abstract “OUTCOME OF PEDIATRIC HODGKIN LYMPHOMA TREATED WITH ABVD: A MULTICENTRIC ANALYSIS OF 335 PATIENTS”. He was Awarded “Abstract Achievement Award” at American Society of Hematology Meeting on Hematological Malignancies Held in Chicago on 16th,17th September ,2016 For The Abstract “Prognostic Significance of Neutrophil-Lymphocyte Ratio in Advanced Pediatric Hodgkin Lymphoma-A Multicentric Analysis of 186 Patients. 


Publications

  • Bhethanabhotla S, Bakhshi S. Reply: Neither Post-Treatment PET-CT Nor Interim PET-CT Using Deauville Criteria Predicts Outcome In Pediatric Hodgkin Lymphoma. J Nucl Med. 2016 Dec8;IMPACT FACTOR: 7.439
  • Bhethanabhotla S, Jain S, Kapoor G, Mahajan A, Chopra A, Vishnubhatla S, Et Al. Outcome Of Pediatric Advanced Hodgkin Lymphoma Treated With ABVD And Predictors Of Inferior Survival: A Multicenter Study Of 186 Patients. Leuk Lymphoma. 2016 Dec 6;1–7. IMPACT FACTOR:2.644
  • Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, Et Al. Post- Treatment PET-CT Rather Than Interim PET-CT Using Deauville Criteria Predicts Outcome In Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET-CT Versus Conventional Imaging. J Nucl Med. 2016 Oct 6; IMPACT FACTOR: 7.439
  • Bhethanabhotla S, Bakhshi S. Presence Of Risk Factors Does Not Affect Outcome In Early Stage Pediatric Hodgkin Lymphoma Treated With ABVD. Ann Hematol. 2016 Nov 18; IMPACT FACTOR: 2.845
  • Taywade SK, Kumar R, Bhethanabhotla S, Bal C. Role Of (18)F-FDG PET-CT In Monitoring The Cyclophosphamide Induced Pulmonary Toxicity In Patients With Breast Cancer - 2 Case Reports. Nucl Med Mol Imaging. 2016 Sep;50(3):261–5.
  • Kakkar A, Rajeshwari M, Bhethanabhotla S, Kaur K, Jain D, Gogia A, Et Al. Primary Diffuse Large B-Cell Lymphoma Of The Prostate: A Report Of Two Cases With Diagnostic Considerations. J Cancer Res Ther. 2015 Dec;11(4):977–9. IMPACT FACTOR: 0.8459
  • Gajendra S, Gogia A, Tanwar P, Sahoo MK, Bhethanabhotla S, Durgapal P, Et Al. Synchronous Metastatic Pulmonary Adenocarcinoma With Small Cell Lymphoma. Leuk Lymphoma. 2014 Jul;55(7):1678–80. IMPACT FACTOR: 2.644
  • Bhethanabhotla S, Thukral A, Sankar MJ, Agarwal R, Paul VK, Deorari AK. Effect Of Position Of Infant During Phototherapy In Management Of Hyperbilirubinemia In Late Preterm And Term Neonates: A Randomized Controlled Trial. J Perinatol. 2013 Oct;33(10):795–9. IMPACT FACTOR: 2.183
  • Kumar L, Boya RR, Pai R, Harish P, Mookerjee A, Sainath B, Et Al. Autologous Stem Cell Transplantation For Multiple Myeloma: Long-Term Results. The National Medical Journal Of India. 2016 Jul 1;29(4):192. IMPACT FACTOR: 0.786
  • Bhethanabhotla, S., Tiwari, A., Sharma, M.C. Et Al. Prognostic Significance Of IL-6 In Hodgkin Lymphoma. Indian J Pediatr. 2019 Mar 4;Online First. IMPACT FACTOR: 1.046
  • Patel A, Tannock I, Bhethanabhola S, Srivastva P, Biswas B, Et Al. Low-Dose Abiraterone In Metastatic Prostate Cancer: Is It Practice Changing? Facts And Facets.JCO Glob Oncol. 2020 Mar;6:382-386. IMPACT FACTOR:1.79


Education

  • MBBS - Osmania Medical College
  • MD - Pediatrics from All India Institute of Medical Sciences
  • DM - Medical Oncology From All India Institute of Medical Sciences


Awards and Recognitions

  • Won Sorel Catherine Prize For Best Post Graduate in Pediatrics For The Year 2012.
  • Stood 2nd in NNF Gold Medal Paper For The Year 2012(1).
  • Received Scholarship For Oral Presentation in SIOP-2015, Cape Town, South Africa For The Abstract “OUTCOME OF PEDIATRIC HODGKIN LYMPHOMA TREATED WITH ABVD: A MULTICENTRIC ANALYSIS OF 335 PATIENTS”.
  • Awarded “Abstract Achievement Award” at American Society of Hematology Meeting on Hematological Malignancies Held in Chicago on 16th,17th September ,2016 For The Abstract “Prognostic Significance of Neutrophil-Lymphocyte Ratio in Advanced Pediatric Hodgkin Lymphoma-A Multicentric Analysis of 186 Patients”


Languages Known

Hindi, English and Telugu


Past Positions

  • Consultant Medical Oncology at Krishna Institute of Medical Sciences
  • Resident Super Specialist at MNJ Institute of Oncology and Regional Cancer Center, Hyderabad
  • Senior Resident In Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi

Doctor Videos

Frequently Asked Questions

Still Have a Question?

If you cannot find answers to your queries, please fill out the enquiry form or call the number below. We will contact you shortly.

+91-40-6810 6585